5D Library › 亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型 · English

第二章 前药与饱和转化:饱和削平峰值

前药的概念与已知的部分

一些这类化合物以前药的形式存在:分子本身活性低,在体内被酶转化为活性物。

证据

去磷酸化(组织匀浆与人体)。 赛洛西宾是磷酸酯,在体内去磷酸化为赛洛新。Horita 与 Weber 1961 年在哺乳动物组织匀浆中证明了这一酶促去磷酸化及其后的氧化 (Horita and Weber 1961);Dinis-Oliveira 综述了赛洛西宾与赛洛新的代谢及其法医毒理学意义 (Dinis-Oliveira 2017)。人体药代动力学方面,Brown 等人在健康成人中作了递增剂量研究,报告了赛洛新的血浆浓度—时间特征 (Brown et al. 2017)。

注

本章不处理的东西。 本章只讨论转化步骤的数学结构。它不给出任何化合物的质量、浓度、剂量或换算关系,不讨论来源、纯度或制备,也不比较不同化合物的效力。全部数值都是无量纲的,相对于一个未指定的参考值。

而乙醯基前药——本书副题中「前药脱乙醯基」所指的那一类——情况不同。

证据

人体转化动力学:未找到已发表数据。 新精神活性物质中的色胺类有综述,但以分析化学、流行病学与毒理报告为主 (Tittarelli et al. 2015)。本书核查未找到乙醯基前药在人体内的脱乙醯基转化动力学(VmaxV_{\max}、KmK_m 或等价参数)的已发表测量。因此本章的模型参数是假设值。若有读者知道已发表的人体转化动力学数据,欢迎通过 5D Library 网站指正。

米氏动力学与两种状态

设前药浓度 AA,活性物浓度 PP,转化由一个可饱和的酶催化,米氏方程 (Johnson and Goody 2011):

dAdt=−VmaxAKm+A−klossA,dPdt=VmaxAKm+A−kelP.\frac{dA}{dt} = -\frac{V_{\max}A}{K_m + A} – k_{\text{loss}}A, \qquad \frac{dP}{dt} = \frac{V_{\max}A}{K_m + A} – k_{el}P.

当 A≪KmA \ll K_m 时转化速率近似为 (Vmax/Km)A(V_{\max}/K_m)A,即一阶;当 A≫KmA \gg K_m 时速率趋于 VmaxV_{\max},即零阶(饱和)。

推导

# Chapter 2. A prodrug converted by a saturable enzyme, in dimensionless
# units. An ester prodrug A is hydrolysed to the active species P, which is
# then eliminated:
#   dA/dt = -Vmax A / (Km + A) - ka_loss A
#   dP/dt = +Vmax A / (Km + A) - kel P
# Concentrations are in units of Km_ref (an arbitrary reference), time in
# units of the elimination half-life of P. NO mass, dose, product, route or
# source appears anywhere in this book; D below is a dose FRACTION relative to
# an unspecified reference exposure. The point is a distinction that is easy
# to get wrong. Saturation of the converting step does NOT make total exposure
# disproportionate: almost all of the prodrug converts eventually either way,
# and mass balance fixes the area under the curve. What saturation changes is
# the SHAPE - the peak and the time to peak - because a saturated enzyme works
# at a fixed rate and spreads the same total conversion over a longer time. So
# the common claim that a saturable prodrug step makes exposure "jump" at
# higher amounts is wrong for total exposure and right for the peak. Which
# regime applies depends on Km, which for the compounds at issue has not been
# measured in humans (Chapter 2 text).
import math

DT, T_END = 0.001, 12.0
KEL = math.log(2.0)          # time unit = elimination half-life of P
KA_LOSS = 0.05               # competing loss of unconverted prodrug

def simulate(D, Km, Vmax=1.0):
    A, P = D, 0.0
    peak, tpeak, auc = 0.0, 0.0, 0.0
    n = int(T_END / DT)
    for i in range(n):
        conv = Vmax * A / (Km + A)
        dA = -conv - KA_LOSS * A
        dP = conv - KEL * P
        A = max(0.0, A + DT * dA)
        P = max(0.0, P + DT * dP)
        auc += P * DT
        if P > peak:
            peak, tpeak = P, (i + 1) * DT
    return peak, tpeak, auc

if __name__ == "__main__":
    print(
        "Dimensionless prodrug model. Time unit = elimination half-life of"
        " the active"
    )
    print(
        "species; concentrations in units of a reference Km. D is a dose"
        " FRACTION.\n"
    )

    print("A. Km = 10 (prodrug far below saturation: first-order regime)")
    print("   D        Cmax      Tmax      AUC      AUC / D")
    base = None
    for D in (0.1, 0.2, 0.5, 1.0, 2.0, 5.0):
        pk, tp, auc = simulate(D, Km=10.0)
        print(
            "   {:6.2f} {:9.4f} {:9.3f} {:9.4f} {:9.4f}".format(
                D, pk, tp, auc, auc / D
            )
        )

    print(
        "\nB. Km = 0.05 (enzyme saturated at these amounts: zero-order"
        " regime)"
    )
    print("   D        Cmax      Tmax      AUC      AUC / D")
    for D in (0.1, 0.2, 0.5, 1.0, 2.0, 5.0):
        pk, tp, auc = simulate(D, Km=0.05)
        print(
            "   {:6.2f} {:9.4f} {:9.3f} {:9.4f} {:9.4f}".format(
                D, pk, tp, auc, auc / D
            )
        )

    print(
        "\nAUC / D is nearly constant in BOTH regimes, and that is the first"
        " thing to"
    )
    print(
        "notice: saturating the converting enzyme does not make total"
        " exposure jump,"
    )
    print(
        "because mass balance fixes it - almost all the prodrug converts"
        " either way."
    )
    print("What saturation changes is the shape:")
    for Km in (10.0, 0.05):
        r1 = simulate(0.5, Km)
        r2 = simulate(5.0, Km)
        print(
            "   Km = {:5.2f}: tenfold D raises Cmax x {:.2f} and Tmax"
            " x {:.2f}".format(Km, r2[0] / r1[0], r2[1] / r1[1])
        )
    print(
        "   Unsaturated, a tenfold rise in D raises the peak almost"
        " tenfold and"
    )
    print(
        "   barely moves its timing. Saturated, the peak rises only 3.5-fold"
        " while"
    )
    print(
        "   the time to peak stretches more than sixfold: the same total"
        " amount is"
    )
    print(
        "   delivered more slowly and more flatly. So a saturable step"
        " BLUNTS the"
    )
    print(
        "   peak rather than amplifying exposure - the opposite of what the"
        " common"
    )
    print("   account of prodrug saturation suggests.")

    print(
        "\nC. The quantity that is NOT known: Km. Sweeping it over three"
        " orders of"
    )
    print("magnitude at a FIXED dose fraction D = 1.0:")
    print(
        "   Km        Cmax      Tmax      AUC    fraction of prodrug"
        " converted"
    )
    for Km in (0.01, 0.05, 0.2, 1.0, 5.0, 20.0):
        pk, tp, auc = simulate(1.0, Km)
        # mass balance: AUC*kel = total P formed
        conv_frac = auc * KEL
        print("   {:7.2f} {:9.4f} {:9.3f} {:9.4f} {:20.3f}"
              .format(Km, pk, tp, auc, conv_frac))

    lo = simulate(1.0, 0.01)
    hi = simulate(1.0, 20.0)
    print(
        "\n   Across that range Cmax varies by a factor of {:.2f} and Tmax by"
        " {:.2f},".format(
            max(lo[0], hi[0]) / min(lo[0], hi[0]),
            max(lo[1], hi[1]) / min(lo[1], hi[1]),
        )
    )
    print(
        "   at the SAME dose fraction. So without a measured Km the model"
        " cannot"
    )
    print(
        "   predict either the peak or its timing, even in these arbitrary"
        " units."
    )
    print(
        "   Chapter 2 argues that this is the actual state of knowledge"
        " for the"
    )
    print(
        "   prodrugs in question: no published human conversion kinetics"
        " exist, so"
    )
    print(
        "   any such curve is parameterised by assumption, not by"
        " measurement."
    )
# Dimensionless prodrug model. Time unit = elimination half-life of the active
# species; concentrations in units of a reference Km. D is a dose FRACTION.
#
# A. Km = 10 (prodrug far below saturation: first-order regime)
#    D        Cmax      Tmax      AUC      AUC / D
#      0.10    0.0094     2.830    0.0756    0.7565
#      0.20    0.0187     2.844    0.1508    0.7539
#      0.50    0.0458     2.882    0.3732    0.7463
#      1.00    0.0890     2.945    0.7338    0.7338
#      2.00    0.1681     3.065    1.4194    0.7097
#      5.00    0.3595     3.389    3.2157    0.6431
#
# B. Km = 0.05 (enzyme saturated at these amounts: zero-order regime)
#    D        Cmax      Tmax      AUC      AUC / D
#      0.10    0.0855     0.268    0.1435    1.4351
#      0.20    0.1651     0.362    0.2863    1.4316
#      0.50    0.3731     0.641    0.7105    1.4210
#      1.00    0.6378     1.093    1.4038    1.4038
#      2.00    0.9658     1.945    2.7420    1.3710
#      5.00    1.3035     4.100    6.4128    1.2826
#
# AUC / D is nearly constant in BOTH regimes, and that is the first thing to
# notice: saturating the converting enzyme does not make total exposure jump,
# because mass balance fixes it - almost all the prodrug converts either way.
# What saturation changes is the shape:
#    Km = 10.00: tenfold D raises Cmax x 7.84 and Tmax x 1.18
#    Km =  0.05: tenfold D raises Cmax x 3.49 and Tmax x 6.40
#    Unsaturated, a tenfold rise in D raises the peak almost tenfold and
#    barely moves its timing. Saturated, the peak rises only 3.5-fold while
#    the time to peak stretches more than sixfold: the same total amount is
#    delivered more slowly and more flatly. So a saturable step BLUNTS the
#    peak rather than amplifying exposure - the opposite of what the common
#    account of prodrug saturation suggests.
#
# C. The quantity that is NOT known: Km. Sweeping it over three orders of
# magnitude at a FIXED dose fraction D = 1.0:
#    Km        Cmax      Tmax      AUC    fraction of prodrug converted
#       0.01    0.6875     1.013    1.4066                0.975
#       0.05    0.6378     1.093    1.4038                0.973
#       0.20    0.5388     1.262    1.3936                0.966
#       1.00    0.3460     1.701    1.3407                0.929
#       5.00    0.1474     2.524    1.0290                0.713
#      20.00    0.0502     3.329    0.4559                0.316
#
#    Across that range Cmax varies by a factor of 13.68 and Tmax by 3.29,
#    at the SAME dose fraction. So without a measured Km the model cannot
#    predict either the peak or its timing, even in these arbitrary units.
#    Chapter 2 argues that this is the actual state of knowledge for the
#    prodrugs in question: no published human conversion kinetics exist, so
#    any such curve is parameterised by assumption, not by measurement.

程序的结果与常见的说法不同,这是本章的要点。

常见的说法是:前药转化饱和会使暴露「跳升」,所以稍微加量就可能出大事。在这个模型里这不成立。看 A、B 两段的 AUC/剂量列:两种状态下它都接近常数。原因是质量守恒——几乎所有前药最终都会转化(C 段的最后一列给出转化比例),而曲线下面积由总转化量与清除率决定,不由转化的速率决定。

饱和改变的是形状。未饱和时,十倍剂量使峰值升高 7.84 倍、达峰时间几乎不动(1.18 倍);饱和时,峰值只升高 3.49 倍、而达峰时间拉长 6.40 倍。也就是说:

饱和的前药步骤把同样的总量更慢、更平地送出去。它削平峰值,不放大暴露。

前药模型在两种状态下的活性物浓度—时间曲线。左:K_m 远大于前药量(一阶转化),剂量比例改变峰高而几乎不改变达峰时间。右:K_m 远小于前药量(饱和),峰被削平而达峰时间大幅拉长。两种状态下曲线下面积与剂量都接近成比例。

注

这不是说饱和无关紧要。 峰值与达峰时间对主观体验的强度与起效感受很可能更重要(第三章说明效应时程还受 ke0 支配)。本章只是指出:哪一个量被饱和改变,常被说反了。如果要论证「加量有风险」,不能用「转化饱和使暴露跳升」这个理由,因为它在这个模型里不成立。

不知道米氏常数的代价

C 段把 KmK_m 在三个数量级上扫过,剂量比例固定。峰值变化 13.68 倍,达峰时间变化 3.29 倍。所以在没有测量 KmK_m 的情况下,模型既不能预测峰值也不能预测它的时点,即使在这些任意单位下也不能。

那么能不能从已发表的数据反推出 KmK_m?下一段程序回答这个问题,而答案出乎意料地是正面的。

推导

# Chapter 2. Can Vmax and Km be recovered from measurements of the ACTIVE
# species alone? This is the practical question for any attempt to
# parameterise the model of p02 from published data, because the prodrug
# itself is usually not assayed. The program fits the two-parameter conversion
# model to a synthetic concentration-time curve of P (sampled at realistic
# times, with 10 % proportional noise) by grid search on the sum of squares,
# and reports the set of (Vmax, Km) pairs that fit within the noise. If that
# set spans orders of magnitude, the parameters are practically unidentifiable
# from such data. Dimensionless units throughout; synthetic data; fixed seed;
# standard library only.
import math
import random

DT, T_END = 0.002, 12.0
KEL = math.log(2.0)
KA_LOSS = 0.05
SAMPLE_T = [0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0]
NOISE = 0.10

def curve(D, Km, Vmax):
    A, P = D, 0.0
    out, want, k = [], sorted(SAMPLE_T), 0
    n = int(T_END / DT)
    for i in range(n):
        t = (i + 1) * DT
        conv = Vmax * A / (Km + A)
        A = max(0.0, A + DT * (-conv - KA_LOSS * A))
        P = max(0.0, P + DT * (conv - KEL * P))
        while k < len(want) and t >= want[k] - DT / 2:
            out.append(P)
            k += 1
    while len(out) < len(SAMPLE_T):
        out.append(P)
    return out

TRUE_KM, TRUE_VMAX, D = 0.30, 1.00, 1.0

def ssq(obs, pred):
    return math.fsum((a - b) ** 2 for a, b in zip(obs, pred))

if __name__ == "__main__":
    rng = random.Random(5202)
    truth = curve(D, TRUE_KM, TRUE_VMAX)
    obs = [v * (1.0 + rng.gauss(0.0, NOISE)) for v in truth]
    print(
        "Truth: Km = {:.2f}, Vmax = {:.2f}. {} samples, {:.0%} proportional"
        " noise.".format(TRUE_KM, TRUE_VMAX, len(SAMPLE_T), NOISE)
    )
    print("Observed active-species curve:")
    for a, b in ((0, 5), (5, len(SAMPLE_T))):
        print(
            "   t    " + "".join("{:8.2f}".format(t) for t in SAMPLE_T[a:b])
        )
        print("   P    " + "".join("{:8.4f}".format(v) for v in obs[a:b]))

    kms = [0.01 * (10 ** (0.1 * k)) for k in range(41)]        # 0.01 .. 100
    vms = [0.1 * (10 ** (0.05 * k)) for k in range(41)]        # 0.1 .. 10
    best, grid = None, []
    for Km in kms:
        for Vm in vms:
            s = ssq(obs, curve(D, Km, Vm))
            grid.append((s, Km, Vm))
            if best is None or s < best[0]:
                best = (s, Km, Vm)
    s0, km0, vm0 = best
    print(
        "\nBest fit: Km = {:.3f}, Vmax = {:.3f} (SSQ {:.3e})".format(
            km0, vm0, s0
        )
    )

    # all pairs within an F-like tolerance of the optimum: a 2-parameter
    # confidence region
    tol = s0 * (1.0 + 2.0 * 2.0 / (len(SAMPLE_T) - 2))
    inside = [(Km, Vm) for s, Km, Vm in grid if s <= tol]
    kmin = min(k for k, _ in inside)
    kmax = max(k for k, _ in inside)
    vmin = min(v for _, v in inside)
    vmax_ = max(v for _, v in inside)
    print(
        "Pairs fitting within the noise tolerance: {} of {}".format(
            len(inside), len(grid)
        )
    )
    print("   Km spans {:.3f} to {:.3f}  (a factor of {:.0f})"
          .format(kmin, kmax, kmax / kmin))
    print("   Vmax spans {:.3f} to {:.3f}  (a factor of {:.1f})"
          .format(vmin, vmax_, vmax_ / vmin))

    print(
        "\nWhat those extremes predict for a FIVEFOLD larger dose fraction:"
    )
    print("   Km      Vmax     Cmax(D=5)   AUC(D=5)")
    def summarise(Km, Vm, Dd):
        A, P, peak, auc = Dd, 0.0, 0.0, 0.0
        for i in range(int(T_END / DT)):
            conv = Vm * A / (Km + A)
            A = max(0.0, A + DT * (-conv - KA_LOSS * A))
            P = max(0.0, P + DT * (conv - KEL * P))
            auc += P * DT
            peak = max(peak, P)
        return peak, auc
    rows = []
    for Km, Vm in ((km0, vm0), (kmin, min(v for k, v in inside if k == kmin)),
                   (kmax, max(v for k, v in inside if k == kmax))):
        pk, au = summarise(Km, Vm, 5.0)
        rows.append((pk, au))
        print("   {:7.3f} {:8.3f} {:11.4f} {:10.4f}".format(Km, Vm, pk, au))
    cmax_spread = max(r[0] for r in rows) / min(r[0] for r in rows)
    auc_spread = max(r[1] for r in rows) / min(r[1] for r in rows)
    print(
        "\n   Curves indistinguishable at D = 1 predict Cmax at D = 5"
        " differing by a"
    )
    print(
        "   factor of only {:.2f} and AUC by {:.2f}.".format(
            cmax_spread, auc_spread
        )
    )

    print(
        "\nThat is a POSITIVE result, and it has to be reported as one. Km"
        " itself is"
    )
    print(
        "recovered only to within a factor of {:.0f}, but the predictions"
        " that matter".format(kmax / kmin)
    )
    print("are robust to that ignorance, because mass balance pins the total")
    print("conversion whatever the enzyme's affinity. So structural")
    print(
        "non-identifiability is NOT the obstacle here: given one decent human"
    )
    print(
        "concentration-time curve, extrapolating exposure to a nearby amount"
    )
    print("would be sound to within tens of per cent.")

    print(
        "\nThe obstacle is that there is no such curve to fit. Compare"
        " the two"
    )
    print("situations directly, both at a fivefold larger dose fraction:")
    def spread_over_km_prior(Dd, kms_prior):
        vals = [summarise(k, 1.0, Dd) for k in kms_prior]
        pk = [v[0] for v in vals]
        return max(pk) / min(pk)
    no_data = spread_over_km_prior(5.0, [0.01, 0.05, 0.2, 1.0, 5.0, 20.0])
    print(
        "   with one fitted curve:        Cmax uncertain by a factor of"
        " {:.2f}".format(cmax_spread)
    )
    print("   with no data, Km only bounded")
    print(
        "   to three orders of magnitude: Cmax uncertain by a factor of"
        " {:.2f}".format(no_data)
    )
    print(
        "\n   The second number is the real state of knowledge for the"
        " prodrugs at"
    )
    print(
        "   issue: no published human conversion kinetics exist, so the curve"
        " is not"
    )
    print(
        "   poorly constrained by data, it is unconstrained by data. The"
        " remedy is a"
    )
    print(
        "   measurement, not a better estimator - and until one exists,"
        " statements of"
    )
    print(
        "   the form 'at a fraction of the usual exposure the kinetics are"
        " linear'"
    )
    print("   are assumptions about Km rather than findings.")
# Truth: Km = 0.30, Vmax = 1.00. 10 samples, 10% proportional noise.
# Observed active-species curve:
#    t        0.25    0.50    0.75    1.00    1.50
#    P      0.1836  0.2445  0.4348  0.4349  0.5006
#    t        2.00    3.00    4.00    6.00    8.00
#    P      0.4044  0.1993  0.1063  0.0276  0.0064
#
# Best fit: Km = 0.316, Vmax = 1.000 (SSQ 6.379e-03)
# Pairs fitting within the noise tolerance: 18 of 1681
#    Km spans 0.050 to 0.631  (a factor of 13)
#    Vmax spans 0.708 to 1.259  (a factor of 1.8)
#
# What those extremes predict for a FIVEFOLD larger dose fraction:
#    Km      Vmax     Cmax(D=5)   AUC(D=5)
#      0.316    1.000      1.1475     6.3330
#      0.050    0.708      0.9577     6.1331
#      0.631    1.259      1.2506     6.4194
#
#    Curves indistinguishable at D = 1 predict Cmax at D = 5 differing by a
#    factor of only 1.31 and AUC by 1.05.
#
# That is a POSITIVE result, and it has to be reported as one. Km itself is
# recovered only to within a factor of 13, but the predictions that matter
# are robust to that ignorance, because mass balance pins the total
# conversion whatever the enzyme's affinity. So structural
# non-identifiability is NOT the obstacle here: given one decent human
# concentration-time curve, extrapolating exposure to a nearby amount
# would be sound to within tens of per cent.
#
# The obstacle is that there is no such curve to fit. Compare the two
# situations directly, both at a fivefold larger dose fraction:
#    with one fitted curve:        Cmax uncertain by a factor of 1.31
#    with no data, Km only bounded
#    to three orders of magnitude: Cmax uncertain by a factor of 6.13
#
#    The second number is the real state of knowledge for the prodrugs at
#    issue: no published human conversion kinetics exist, so the curve is not
#    poorly constrained by data, it is unconstrained by data. The remedy is a
#    measurement, not a better estimator - and until one exists, statements of
#    the form 'at a fraction of the usual exposure the kinetics are linear'
#    are assumptions about Km rather than findings.

结果分两层。第一层:从单一暴露下活性物的浓度—时间曲线(10 个采样点、10% 比例噪声)拟合,KmK_m 只能定到 13 倍以内,VmaxV_{\max} 定到 1.8 倍以内。单看这个,参数是定不准的。

第二层是要点:这些在 D=1D = 1 处无法区分的曲线,在 D=5D = 5 处预测的峰值只差 1.31 倍、AUC 只差 1.05 倍。原因还是质量守恒:无论酶的亲和力如何,总转化量都被约束住了。所以

结构不可识别性不是这里的障碍。有一条像样的人体浓度—时间曲线可拟合,把暴露外推到相近的量就能做到几十个百分点的精度。

真正的障碍是没有那条曲线。程序最后把两种处境并排:有一条拟合曲线时峰值的不确定度是 1.31 倍;没有数据而 KmK_m 只能在三个数量级内取值时,不确定度是 6.13 倍。第二个数字是这类前药的实际知识状态。

注

为什么要把正面结果写出来。 按第 33 本的立场,无论结果支持还是不支持作者的框架都照实写。这里的结果对「模型不可用」这一悲观判断是不利的:模型是可用的,只要有一次测量。把它写成「参数不可识别所以什么都说不了」会是一个更戏剧化但错误的结论,而错误的悲观与错误的乐观同样有害——它会让人以为这类问题原则上无解,从而不去做那个本来能解决问题的测量。

假说 · 尚未验证

作者的假说(尚未确立): 对乙醯基前药,人体内的脱乙醯基转化在本书所讨论的暴露范围内是一阶的(即 A≪KmA \ll K_m),因此活性物的暴露与前药的量近似成比例,且达峰时间与剂量基本无关。什么样的结果能证明它是错的: 在取得监管批准的人体药代动力学研究中,若达峰时间随剂量系统性延长(例如最高与最低剂量组的达峰时间比的 95% 置信区间下限大于 1.5),则本假说错。注意本假说不对任何剂量作出判断,它只对动力学的函数形式作出判断。

本章小结

赛洛西宾的去磷酸化自 1961 年起就有组织匀浆证据,其代谢有综述,人体药代动力学有递增剂量研究。乙醯基前药的人体转化动力学,本书核查未找到已发表数据,所以本章的米氏参数是假设值。模型给出一个方向与常见说法相反的结果:饱和的前药步骤不使总暴露跳升——质量守恒把 AUC 固定住——而是削平峰值并拉长达峰时间(十倍剂量下,未饱和时峰值升 7.84 倍、达峰时间 1.18 倍;饱和时峰值升 3.49 倍、达峰时间 6.40 倍)。不知道 KmK_m 时,同一剂量比例下峰值的不确定度达 13.68 倍。但从单一暴露的曲线拟合给出一个正面结果:KmK_m 虽只定到 13 倍以内,五倍暴露下的峰值预测只差 1.31 倍,因为质量守恒约束了总转化。所以障碍不是不可识别性,而是没有数据可拟合——此时峰值的不确定度是 6.13 倍。

参考文献

Brown, Randall T., Christopher R. Nicholas, Nicholas V. Cozzi, Michele C. Gassman, Karen M. Cooper, Daniel Muller, Chantelle D. Thomas, et al. 2017. “Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.” Clinical Pharmacokinetics 56 (12): 1543–54. https://doi.org/10.1007/s40262-017-0540-6.
Dinis-Oliveira, Ricardo Jorge. 2017. “Metabolism of Psilocybin and Psilocin: Clinical and Forensic Toxicological Relevance.” Drug Metabolism Reviews 49 (1): 84–91. https://doi.org/10.1080/03602532.2016.1278228.
Horita, Akira, and L. J. Weber. 1961. “The Enzymic Dephosphorylation and Oxidation of Psilocybin and Psilocin by Mammalian Tissue Homogenates.” Biochemical Pharmacology 7: 47–54. https://doi.org/10.1016/0006-2952(61)90124-1.
Johnson, Kenneth A., and Roger S. Goody. 2011. “The Original Michaelis Constant: Translation of the 1913 Michaelis–Menten Paper.” Biochemistry 50 (39): 8264–69. https://doi.org/10.1021/bi201284u.
Tittarelli, Roberta, Giulio Mannocchi, Flaminia Pantano, and Francesco Saverio Romolo. 2015. “Recreational Use, Analysis and Toxicity of Tryptamines.” Current Neuropharmacology 13 (1): 26–46. https://doi.org/10.2174/1570159X13666141210222409.

Fan, Y. (2026). Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica [亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型] (Version 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24019347 · Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).